Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype

Clinical Pharmacology and Therapeutics
K BrøsenL F Gram

Abstract

Eighteen healthy volunteers, selected according to their ability to oxidize sparteine, took single oral doses of 100 mg imipramine and desipramine. For imipramine the following clearances (L X min-1) were found in six rapid extensive metabolizers (EM), six slow EM, and six poor metabolizers (PM), respectively (mean and range): apparent oral clearance: 2.55 (1.39 to 3.47), 2.28 (1.18 to 4.26), and 1.35 (0.96 to 1.64). Clearance via demethylation was: 1.42 (0.61 to 2.01), 1.60 (0.78 to 3.81), and 1.09 (0.76 to 1.64); clearance via other pathways was: 1.13 (0.74 to 1.75), 0.69 (0.40 to 1.59), and 0.26 (0 to 0.46). For desipramine the apparent oral clearance (L X min-1) was 0.19 (0.12 to 0.24) in PM compared with 1.64 (1.46 to 1.80) and 1.03 (0.77 to 1.13) in rapid EM and slow EM. Extremely long elimination t1/2s of desipramine were seen in PM: 81 to 131 hours compared with 13 to 23 hours in EM. 2-OH-imipramine and 2-OH-desipramine were detectable in plasma of only the 12 EM, where the ratio-to-parent compound was higher in rapid EM than in slow EM. This study confirms that 2-hydroxylation of imipramine and desipramine depends almost exclusively on the sparteine oxygenase, whereas the demethylation of imipramine depends mainly on a...Continue Reading

Citations

Sep 1, 1992·British Journal of Clinical Pharmacology·E Skjelbo, K Brøsen
Mar 20, 1998·Journal of Clinical Pharmacology·J T CallaghanG V Kondraske
Dec 4, 2003·European Journal of Clinical Investigation·I Cascorbi
May 10, 2013·European Journal of Clinical Pharmacology·Ingolf CascorbiAnneke N Werk
Jan 1, 1989·European Journal of Clinical Pharmacology·K Brøsen, L F Gram
Nov 1, 1990·British Journal of Clinical Pharmacology·S H SindrupH Beck-Nielsen
Oct 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Sep 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y HoraiH J Dengler
Aug 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Oct 2, 2003·Journal of Clinical Psychopharmacology·Julia KirchheinerJürgen Brockmöller
Nov 11, 2003·Clinical Pharmacokinetics·David R P Guay
Dec 22, 2005·Anesthesia and Analgesia·Thomas P EnggaardSøren H Sindrup
Sep 14, 2006·Pharmacological Reviews·Sharon J Gardiner, Evan J Begg
Nov 8, 2007·The Annals of Pharmacotherapy·Milo Gibaldi
Oct 13, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 29, 2017·European Journal of Clinical Pharmacology·Sijie LuA S Gross
Jan 1, 1989·European Journal of Clinical Pharmacology·K Brøsen, L F Gram
Feb 1, 1989·British Journal of Clinical Pharmacology·L F GramE Zarifian
Apr 1, 1987·Pharmacology & Toxicology·K BrøsenL Bertilsson
Nov 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·D Taylor
Jun 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B PfandlU Breyer-Pfaff
Mar 1, 1997·Clinical Pharmacology and Therapeutics·H MadsenK Brøsen
Sep 1, 2010·Expert Review of Clinical Pharmacology·Ingolf Cascorbi
Jan 1, 1988·Acta Psychiatrica Scandinavica. Supplementum·L F Gram
Jan 1, 1993·European Journal of Clinical Pharmacology·K BrøsenL F Gram
Jan 1, 1991·Fundamental & Clinical Pharmacology·G Alván
Feb 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Jan 1, 1992·European Journal of Clinical Pharmacology·S H SindrupH Beck-Nielsen
Sep 1, 1994·Journal of Clinical Pharmacology·D G May
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A Bernard, E Bruera
Apr 1, 1989·British Journal of Clinical Pharmacology·E J BeggD W Clark
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.